Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 16 May 2024
      #Imagine if people living with rare diseases had a better chance to live a healthy life


Hear more from David Loew, second Vice President, EFPIA, and CEO Ipsen.

 
 
      News
 
  13 May 2024 Joint business statement on the EU Proposal on Compulsory Licensing

We believe that, in its current form, this initiative will undermine innovation and competitiveness of European companies,...

Read more →
 
 
 
      Blogs
 
  16 May 2024 Advancing Clinical Trials for European Patients

Now is the time to catalyse healthcare innovation – improving patients’ lives and restoring Europe as a powerhouse for...

Read more →
 
 
 
  15 May 2024 Patient involvement in HTA

Health Technology Assessments: What can we learn from experiences across Europe?

Read more →
 
 
 
  04 June 2024 Countdown to the EU HTA: how can we seize this opportunity to improve patient access to medicines?...

In January 2025, all new cancer medicines and advanced therapy medicinal products (ATMPs) will be jointly assessed at...

Read more →
 
 
 
      Join EFPIA as an Associate Director, Health Systems

Passionate about shaping European healthcare policy? EFPIA is looking for an Associate Director to join the health systems team.

 

Learn more about the position here.

 
 
 
      Events
 
 
23 MAY 2024
  Innovative Approaches to Regulatory Reliance Virtual event

Global Trends and Perspectives for Latin America and the Caribbean

Learn more →
 
 
 
27 MAY 2024
  Five ways to reduce cancer care inequalities in Europe: Looking beyond the elections.... Online event

From May 27th to May 31st, 2024, CPE will host a series of daily 45 minute webinars addressing actionable steps to reduce...

Learn more →
 
 
      Event report "Digitally-enabled healthcare: Is our ecosystem on track?"

On 7 March 2024, the EU Health Coalition organised an event to discuss the current state of digital transformation within healthcare systems and address the fundamental challenges that hinder the acceleration of the data-driven revolution.

 

Read the event report and watch the recording.

 

 
 
      What we are reading
From resistance to resilience: what could the future antibiotic pipeline look like? 14 May 2024  (IFPMA) Read more →
Enabling, not rewarding 13 May 2024  (Copenhagen Economics) Read more →
France: Europe’s highest tax burden for pharma industry, lobby warns 03 May 2024  (Euractiv) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe